title: Donor-soluble histocompatibility antigen selectively potentiates suppressor elements while decreasing the frequency of alloantigen-specific T cytotoxic cells.
authors.affiliation: Department of Surgery, University of Texas Medical School at Houston.
authors.forename: S M
authors.initials: SM
authors.lastname: Stepkowski
authors.forename: R
authors.initials: R
authors.lastname: Ghobrial
authors.forename: B
authors.initials: B
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Ito
authors.forename: S
authors.initials: S
authors.lastname: Goto
authors.forename: T
authors.initials: T
authors.lastname: Hamashima
authors.forename: B D
authors.initials: BD
authors.lastname: Kahan
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000008:administration & dosage*; D007165:Immunosuppression Therapy / Q000379:methods*; D008221:Lymphoid Tissue / Q000528:radiation effects; D051381:Rats; D011915:Rats, Inbred BUF; D011920:Rats, Inbred WF; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D014019:Tissue Donors; D014184:Transplantation, Homologous
chemical_list: D006649:Histocompatibility Antigens; C038353:histocompatibility antigens RT, rat; D016572:Cyclosporine